What is this collection about? 

Antimicrobial resistance (AMR) presents an escalating global health crisis, threatening the effectiveness of antibiotics and related treatments. Genomic technologies have transformed our understanding of resistance, allowing scientists to track and combat AMR at the molecular level. This Collection seeks to bring together research exploring the genomic characterization of resistant strains, the spread of resistance through horizontal gene transfer, and the use of metagenomics, databases, and tools for diagnostics and surveillance. The submission deadline is 24 March 2026.

Why is this collection important? 

As we face mounting public health challenges posed by AMR, genomic insights are becoming crucial to guiding prevention, treatment, and surveillance strategies. This Collection is especially timely, encouraging cross-disciplinary collaboration and innovation in tackling a problem of global scale. It supports and amplifies research aligned with the UN’s Sustainable Development Goal 3: Good Health and Well-being. Researchers have an opportunity to be part of a vital conversation that could influence health policy and practice. 

Why submit to a collection? 

Collections like this one help promote high-quality science. They are led by Guest Editors and In-House Editors who are experts in their fields and supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one-stop-shop on a cutting-edge topic of interest.

Who is involved? 

Kate S. Baker, PhD – University of Cambridge, UK
Kate S Baker is a veterinary-trained infectious disease expert who leads the Pathogen Dynamics Unit at Cambridge. Her research integrates genomic epidemiology and lab studies to investigate AMR in key pathogens, influencing public health policy in both high- and low-income settings.

Danielle J. Ingle, PhD – The University of Melbourne, Australia
Dr Danielle Ingle is an NHMRC Fellow whose research spans genomic epidemiology and molecular microbiology of priority pathogens including Salmonella, E. coli, and Shigella. Her work supports public health surveillance in Australia and globally by uncovering bacterial evolutionary dynamics.

Elizabeth A. Cummins, PhD – University of Oxford, UK
Dr Elizabeth Cummins is a postdoctoral researcher at Oxford, focused on genomic mechanisms behind multidrug resistance in E. coli and Staphylococcus aureus. Her work explores how bacterial genomes evolve to acquire and maintain resistance genes.

How can I submit my paper? 

Visit the Collection page to find out more about this collection and submit your article.